Skip to content
MarketScale
‹ Back to IndustriesHealthcare

What Does it Mean to be ONC Certified and Why Does It Matter?

Technology has become an integral part of our society, and today’s healthcare industry, physicians, and their offices need capable and secure ways to store data. Efficient EHR systems allow healthcare practices to receive and transfer patient data, manage personnel, and more. As this critical industry continues to expand, the Office of the National Coordinator for…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Technology has become an integral part of our society, and today’s healthcare industry, physicians, and their offices need capable and secure ways to store data. Efficient EHR systems allow healthcare practices to receive and transfer patient data, manage personnel, and more.

As this critical industry continues to expand, the Office of the National Coordinator for Health Information Technology (ONC) established standards for structured data that EHR programs must meet to become certified. And EHR providers, like ChartLogic, can volunteer to have the ONC review their product for certification.

What is ONC Certification?

The ONC established its Health IT Certification Program under the Public Health Service Act. This act designed the program to set standards for the evolving health information technology sector. A third-party tests EHR programs for their recording, security, and information sharing capabilities, only awarding certification to providers meeting ONC standards.

Medical providers must use ONC-certified EHR systems to receive Medicaid and Medicare incentive payments. Furthermore, this certification allows providers and patients to feel more confident in the way health information is stored and used.

Accreditation Labs and Certification Bodies

With such a vital certification, it’s critical to find third-party laboratories to review the submitted EHRs. As of now, the ONC only works with four labs to complete certification:

  • Drummond Group
  • ICSA Labs
  • InfoGard Laboratories, Inc.
  • SLI Compliance, a Division of Gaming Laboratories International, LLC

With experience in a variety of industries, including healthcare, the neutral testing group SLI Compliance, a Division of Gaming Laboratories International, LLC tested and certified ChartLogic EHR 9 with 2015 Edition Health IT Module.

What This Means for Physicians and Patients

Because third-party laboratories test the software, medical professionals that opt for an ONC-certified EHR don’t have to take the word of a service provider—EHRs that are not secure, trustworthy, or functional don’t receive ONC certification. This means staff and physicians can rest easy knowing their software meets rigorous Health IT requirements.

Implementing an ONC-certified program also allows a physician’s office to earn more money. Offices can avoid Medicare payment adjustments and receive their respective Medicaid incentive payments, all while making life easier for a practice’s staff and patients.

As more medical professionals implement programs that meet these standards, patients stand to benefit as well. EHR systems make managing their health care easier than ever. Furthermore, because the certified systems are more secure than others, patients’ personal information remains private.

Read more at chartlogic.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended AstraZeneca and Daiichi Sankyo’s Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly is investing $6.5 billion in a Houston manufacturing facility set to open around 2030, primarily to scale production of Foundayo, its oral GLP-1 treatment. The project signals a broader shift in U.S. pharmaceutical manufacturing reshoring and underscores the supply chain challenge of forecasting demand and building capacity years in advance for breakthrough therapeutics.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512